| Description | BCR-ABL1-IN-1 is a highly potent and orally bioavailable inhibitor, displaying remarkable specificity towards ABL kinase. Notably, this compound holds significant promise for delineating the precise involvement of ABL kinases within the central nervous system, particularly in preclinical investigations [1]. |
| molecular weight | 359.3 |
| Molecular formula | C18H12F3N3O2 |
| CAS | 1488090-21-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |